At a glance
- Originator Sankyo
- Class
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 07 Feb 2001 No-Development-Reported for Influenza virus infections in Japan (Unknown route)
- 10 Jun 1998 New profile
- 10 Jun 1998 Preclinical development for Influenza virus infections in Japan (Unknown route)